This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Biotherapy

Biotherapy is a broad cancer-treatment category covering biological therapy, biologic response modifiers, immunotherapy, monoclonal antibodies, cytokines, cancer vaccines, cell therapies, oncolytic viruses, and related biologic approaches that change immune or tumor biology. Overview Biotherapy, also called biological therapy or biological response modifier therapy in older oncology literature, is a broad cancer-treatment category built around living systems and biologically derived substances.

Doctors

Bruce A. Chabner

medical oncologist

Medical oncologist and cancer pharmacology researcher associated with Massachusetts General Hospital, Harvard, the NCI, and Abeloff's Clinical Oncology. Bruce A. Chabner, MD, is a medical oncologist and cancer pharmacology researcher. AACR notes his work on antifolates, antimetabolites, paclitaxel development, and high-dose chemotherapy regimens. He has been associated with Massachusetts General Hospital Cancer Center and Harvard, and served as editor-in.
WebsiteWikipedia

Dr. Patrick Soon-Shiong

doctor, surgeon | Abraxis BioScience, ANKTIVA, Cancer MoonShot 2020 / Cancer Breakthroughs 2020, Chan Soon-Shiong Family Foundation, Chan Soon-Shiong Institute for Medicine, Chan Soon-Shiong Institute of Molecular Medicine, ImmunityBio, Los Angeles Times, NantHealth, NantKwest, NantOmics, NantWorks

South African-born American surgeon, billionaire biotech entrepreneur, inventor of Abraxane, founder/executive of Immunity Bio/Nant companies, and developer/promoter of ANKTIVA/NANT Cancer Vaccine immunotherapy platforms. Patrick Soon-Shiong is a physician and biotechnology entrepreneur associated with cancer immunotherapy, including immune activation and natural killer cell-related approaches. Patrick Soon-Shiong, M. D.
WebsiteWikipedia
All Protocols